Using in vitro assays of osteoclastogenesis and bone resorption, it was shown that enhanced osteoclastogenesis also requires the presence of syndecan-1, a proteoglycan whose shedding from tumor cell surfaces is enhanced by the expression of heparanase and protein agents, such as IL-8 [31]. This evidence concerns the gene CXCL8 and neoplasm.